News - Cubist Pharmaceuticals, Theravance


Popular Filters

Majority of US surveyed MCOs will consider reimbursing novel OPAT agents; report


According to surveyed physicians in the USA, the use of out-patient parenteral antibiotic therapy (OPAT)…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsForest LaboratoriesIvanzMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalTeflaroTheravanceVibativ

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top